Who We Are?

The company was founded in 1999 by Dr Sherif Waly, a pharmacist with a big deal of experience in pharmaceutical society. Sherif was a member of board in CID, Mepaco and Egyblood, Companies For more than 6 years.
Dr Moustafa Awad and Dr Monda Kelada joined as partners in 2002 
Dr Moustafa Awad is a professional sales person with a long history with multinational companies in Glaxo Allergan and Alcon pharmaceutical companies. He is now board member in Future Pharma Company.

Dr Monda Kelada, is a physician with a good experience in marketing pharmaceuticals as she worked with Rhone Poulenc Santé, De Lagrange pharmaceutical companies, Pasteur vaccines. Monda has a proven record of success in launching of new products.
The company is specialized in promoting medical pharmaceuticals for all specialties, training professional executives in pharmaceutical industry and manufacturing new products.
Our medical representative reaches Marsa Matrouh, Sharm Elsheikh and South Aswan covering all the areas in between with resident representatives 
The company has got 150 professional medical representatives and field force supervisors that are very well trained to promote very specialized and ethical pharmaceutical products.

A-Marketing
The company started its activities in 1999 by promoting an ophthalmic line of six products from Amoun Pharmaceutical Company with a turnover of one million pounds per year.
After a tremendous success of the line, in 2002 the products were increased to 34 ethical products for all specialties.

Pharmaceutical Groups 
We are working on a very wide range of pharmaceutical groups that are:
1-Ophthalmology
2-Gastroenterology
3- Neuropsychiatry
4-Antibiotics
5-Antireheumatics
6-Diabetology
7- Dermatology
8-Cardiology
9-Chest
10-Pediatrics

The turnover was 38 million pounds 
In 2004 the products line increased to 44 products divided over two lines beside the two lines dedicated to Amoun, we created a third line for Queen Pharm and Global Napi
In 2007 we added a fourth line for all ELAMIRYA pharmaceutical
(9 ethical products).

By the end of 2011 the company targeted 95 Million pounds and proudly achieved the target.

B-Training & Consultancy
Pharma mix began this important activity in 2005 after contracting with industrial modernization center.
Our data base includes more than 30 trainers, and consultants 
Pharma mix have executed more 144 training course for more than 16 pharmaceutical companies
Pharma mix have completed eight consultancies with six companies in all fields of Marketing, Corporate Image building and Eu GMP.

New products
Pharma Mix began registering new products since 2006 by the end of 2012 the company portfolio of products will be around 10 products covering five therapeutic groups Pharma Mix co-operate with four of the most and reputable firms manufacturing these products.